Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metoprolol in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease

NCT06825728 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT06825728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06825728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metoprolol in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease
Lead sponsor
Xiangya Hospital of Central South University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
February 29, 2028
Enrollment
311 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease), heart failure with reduced ejection fraction (hfref)